Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 21 for “"Indium - 111"”.

  1. Panitumumab Modified with Metal Chelating Polymers (MCPs) Complexing Indium‐111 and Lutetium-177 as Theranostics for Pancreatic Cancer

    … emitter, 177Lu and Auger electron-emitter, 111In and 10 polyethylene glycol (PEG) chains was conjugated to monoclonal antibody, panitumumab to target EGFR on PANC-1 human PnCa cells. Linking panitumumab to MCPs enabled dual labeling with 111In and 177Lu at a higher SA (55.9± 4.8 MBq/μg and …

    toronto-retro Repository record for Panitumumab Modified with Metal Chelating Polymers (MCPs) Complexing Indium‐111 and Lutetium-177 as Theranostics for Pancreatic Cancer (opens in a new tab)

  2. Development of labelled platelets as radiopharmaceuticals

    … of the labelled cells. The two labelling agents,indium-111 oxine and indium-111 tropolone were used and indium-111 oxine was found to be the superior platelet labelling agent. Maintenance of viability was demonstrated using in vitro aggregation tests. Having established a successful labelling …

    aston Repository record for Development of labelled platelets as radiopharmaceuticals (opens in a new tab) Download PDF for Development of labelled platelets as radiopharmaceuticals (opens in a new tab)

  3. Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy

    … have been demonstrated using the AE emitter indium-111. </p> <p>Firstly, PAR is demonstrated using poly (methyl methacrylate) (PMMA). Photoresists were exposed to indium-111 which had been internalised into cells, and the photoresists were analysed using atomic force microscopy (AFM). The …

    oxford Repository record for Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy (opens in a new tab)

  4. The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy

    … chelator (DTPA) to allow radiolabelling with indium-111. The radioiodination of MST-312, BIBR-1532 and flavonoid-derived small molecule inhibitors of telomerase was also pursued. The inhibitory activity of the candidate molecules was analysed using the telomeric repeat amplification protocol …

    oxford Repository record for The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy (opens in a new tab)

  5. A photoluminescence study of indium implanted silicon

    The results of a photolummescence (PL) study of indium implanted silicon are presented. When silicon implanted with indium is annealed in the temperature range 400°C to 700°C a sharp no-phonon line at 1096 6 ± 0 1 meV with an associated phonon sideband is produced in the PL spectra Usmg uniaxial …

    dcu Download PDF for A photoluminescence study of indium implanted silicon (opens in a new tab)

  6. Metal chelating agents for medicinal radionuclides

    … of H4pypa with scandium-44, lutetium-177, indium-111, yttrium-86, zirconium-89, and H4py4pa with actinium-225 were conducted, while their biological properties were evaluated with either the peptide- or the antibody-conjugates, showing favorable radiolabeling results and stability which …

    ubc Repository record for Metal chelating agents for medicinal radionuclides (opens in a new tab) Download PDF for Metal chelating agents for medicinal radionuclides (opens in a new tab)

  7. Zirconium-89 Complexes for Cell Tracking with Positron Emission Tomography

    … with gamma-emitting radionuclides (especially indium-111) is a well-established clinical and research tool. Positron emission tomography offers improved sensitivity and resolution, but there are no established cell labelling methods using suitable long-lived isotopes. The long half-life …

    kent Download PDF for Zirconium-89 Complexes for Cell Tracking with Positron Emission Tomography (opens in a new tab)

  8. Η εφαρμογή του ραδιοεπισημασμένου αναλόγου της σωματοστατίνης ⁹⁹ᵐTc-depreotide στην διαγνωστική προσέγγιση του μεταστατικού καρκίνου του θυρεοειδούς

    … analogue of the endogenous hormone somatostatin, indium-111-labeled DTPA-octreotide (¹¹¹In-pentetreotide), for the detection of iodine-negative metastases of differentiated thyroid cancer, as well as medullary thyroid cancer metastatic lesions. The aim of the present study was the evaluation of …

    greece Repository record for Η εφαρμογή του ραδιοεπισημασμένου αναλόγου της σωματοστατίνης ⁹⁹ᵐTc-depreotide στην διαγνωστική προσέγγιση του μεταστατικού καρκίνου του θυρεοειδούς (opens in a new tab)

  9. Immuno-SPECT imaging of aberrant p53 expression in pancreatic ductal adenocarcinoma

    … DTPA-49A1/H10-TAT was further radiolabelled with indium-111 radionuclide [111In] to yield [111In]-DTPA-49A1/H10-TAT.</p> <p>The cellular uptake and retention of [111In]-DTPA-49A1/H10-TAT were investigated in three PDAC cell lines with varying p53 expression. Having completed the in vitro …

    oxford Repository record for Immuno-SPECT imaging of aberrant p53 expression in pancreatic ductal adenocarcinoma (opens in a new tab)

  10. Folate Receptor Alpha Targeted Delivery And Characterization Of Polyethyleneimine-Graft-Polycaprolactone-Block-Poly(ethylene Glycol) Containing Sirna Micelleplexes

    … tumor growth and luciferase knockdown. While Indium-111 labeled siRNA was designed to monitor siRNA whole body distribution, tumor targeting, and pharmacokinetic parameters by SPECT/CT and gamma scintillation counting. Upon I.P. injection, both the targeted and non-targeted siRNA containing …

    wayne-thes Repository record for Folate Receptor Alpha Targeted Delivery And Characterization Of Polyethyleneimine-Graft-Polycaprolactone-Block-Poly(ethylene Glycol) Containing Sirna Micelleplexes (opens in a new tab)

  11. Generierung muriner monoklonaler Antikörper und gentechnische Herstellung spezifischer Fab-Fragmente gegen die tumorassoziierte Isoform 1 des humanen Tenascin C für die Radioimmuntherapie von Gliomen

    … Evaluation wurden die mAk und Fab-Fragmente mit Indium-111-DTPA radiomarkiert und in U87MG-tragenden SCID-Mäusen getestet. Der mAk mit der höchsten Avidität (WGGD4-B4) wies eine spezifische Bindung mit hoher Affinität (KD ~ 35 nM ± 16 nM) an WHO°III und WHO°IV Gliome auf. Gesunde Hirnareale …

    lmu-germany Repository record for Generierung muriner monoklonaler Antikörper und gentechnische Herstellung spezifischer Fab-Fragmente gegen die tumorassoziierte Isoform 1 des humanen Tenascin C für die Radioimmuntherapie von Gliomen (opens in a new tab)

  12. Telomerase-targeting radiopharmaceuticals for the selective treatment of cancer

    … and nuclear localisation of transfected Indium-111(<sup>111</sup>In)-labelled oligonucleotides, targeted to the RNA template of telomerase (hTR), resulted in a telomerase-dependent cytotoxic induction of DNA double-strand breaks. </p> <p><b>Aim</b></p> <p>The aim of this DPhil project was …

    oxford Repository record for Telomerase-targeting radiopharmaceuticals for the selective treatment of cancer (opens in a new tab)

  13. Targeted Auger Electron Radiotherapy of HER2-amplified Breast Cancer

    … research was to radiolabel trastuzumab with [111]In, and to modify it with peptides harboring the NLS (CGYGPKKKRKVGG) of the simian virus 40 large-T antigen for targeted radiotherapy of breast cancer. It was hypothesized that the NLS-peptides would mediate the translocation of covalently …

    toronto-retro Repository record for Targeted Auger Electron Radiotherapy of HER2-amplified Breast Cancer (opens in a new tab)

  14. Trastuzumab Metal Chelating Polymer (MCP) Radioimmunoconjugates for Auger Electron Radioimmunotherapy of Breast Cancer

    … acid (DTPA) for complexing 111In (111In-DTPA-NLS-trastuzumab) has shown promise for Auger electron radioimmunotherapy of HER2-positive breast cancer (BC), but a limitation is the low specific activity (SA) achievable for labeling with 111In. Our objective was to synthesize …

    toronto-retro Repository record for Trastuzumab Metal Chelating Polymer (MCP) Radioimmunoconjugates for Auger Electron Radioimmunotherapy of Breast Cancer (opens in a new tab)

  15. Optimum ¹¹¹In okine labelled autologous leukocytes

    … effectively will be subsequently labelled with 111In oxine. As in all radiopharmaceuticals, the highest radiopharmaceutical purity, or the fraction of total radioactivity in the desired radiopharmaceutical form (111In oxine leukocyte), the better the product. Many 111In ocine labelled leukocytes …

    u-pacific Repository record for Optimum ¹¹¹In okine labelled autologous leukocytes (opens in a new tab)

  16. EGFR and HER2-targeted radioimmunoconjugates for theranostic molecular imaging and Auger electron radioimmunotherapy of breast cancer

    … with DOTA chelators for radiolabelling with 111In for SPECT imaging and Auger electron (AE) radioimmunotherapy (RIT). [99mTc]His6-pertuzumab Fab exhibited saturable specific binding to BC cells in vitro (Kd = 51.3 ± 5.2 x 10-9 M). SPECT/CT at 24 h p.i. discriminated between HER2-positive …

    toronto-retro Repository record for EGFR and HER2-targeted radioimmunoconjugates for theranostic molecular imaging and Auger electron radioimmunotherapy of breast cancer (opens in a new tab)

Page 1 of 2